Table 3.
Obstacles in the treatment of early Crohn’s disease
| ❑ Difficulty in obtaining adequate number of patients with truly early disease |
| ❑ Overlap between early and late mechanisms |
| ❑ Variability of the clinical, pathological and immunological spectrum of CD |
| ❑ Lack of reliable biomarkers associated with early or late disease |